Related Experiment Videos

Dopamine effect on the mitochondria potential in B lymphocytes of schizophrenic patients and normal controls

Ahmed M Elkashef1, Heba Al-Barazi, Dianne Venable

  • 1Clinical Trials Branch, NIDA, Bethesda, MD 20892-9551, USA. ae8a@nih.gov

Insights

Dopamine (DA) impairs mitochondrial function in cell models, but this mechanism was not evident in schizophrenia patients. Further research is needed to understand brain metabolic abnormalities in schizophrenia.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Schizophrenia is associated with brain metabolic abnormalities and altered dopamine (DA) metabolism.
  • Increased free radical generation from DA metabolism by monoamine oxidase (MAO) may damage mitochondria.

Purpose of the Study:

  • To investigate the hypothesis that mitochondria are a primary target of damage in schizophrenia due to increased DA metabolism.
  • To examine the effect of DA on mitochondrial membrane potential in Epstein-Barr virus (EBV)-transformed B-lymphocytes from schizophrenia patients and normal controls.

Main Methods:

  • EBV-transformed B-lymphocytes from schizophrenia patients and controls were incubated with DA, H2O2, or rotenone (Rot).
  • Mitochondrial membrane potential was assessed by rhodamine 123 (Rh 123) uptake using flow cytometry.

Main Results:

  • DA significantly decreased Rh 123 uptake, indicating impaired mitochondrial membrane potential, similar to H2O2 or Rot treatment.
  • No significant differences in Rh 123 uptake were observed between cells from schizophrenia patients and normal controls.

Conclusions:

  • Dopamine can impair mitochondrial membrane potential.
  • This specific mechanism of DA-induced mitochondrial dysfunction may not be directly evident or applicable in schizophrenia patients.

Related Concept Videos